Delivery of nucleic acids into eukaryotic genomes using in vitro assembled Mu transposition complexes
AssigneeFinnzymes Oy
InventorsHarri Savilahti, Mikko Frilander, Xiaojuan Meng, Anja Paatero, Maria Pajunen, Hilkka Turakainen
Life of this patent
Estimating the term…
Abstract
The present invention relates to genetic engineering and especially to the use of DNA transposition complex of bacteriophage Mu. In particular, the invention provides a gene transfer system for eukaryotic cells, wherein in vitro assembled Mu transposition complexes are introduced into a target cell and subsequently transposition into a cellular nucleic acid occurs. The invention further provides a kit for producing insertional mutations into the genomes of eukaryotic cells. The kit can be used, e.g., to generate insertional mutant libraries.
Claims10
A method for incorporating nucleic acid segments into cellular nucleic acid of an isolated mammalian target cell, the method comprising the step of:
- delivering into the mammalian target cell an in vitro assembled Mu transposition complex that comprises (i) MuA transposases and (ii) a transposon segment that comprises a pair of Mu end sequences recognised and bound by MuA transposase and an insert sequence between said Mu end sequences, wherein the transposon segment is integrated by transposition into the cellular nucleic acid of said target cell and the integration is mediated by MuA only.
A method for forming an insertion mutant library from a pool of mammalian target cells, the method comprising the steps of:
- a) delivering into a mammalian target cell an in vitro assembled Mu transposition complex that comprises (i) MuA transposases and (ii) a transposon segment that comprises a pair of Mu end sequences recognised and bound by MuA transposase and an insert sequence with a selectable marker between said Mu end sequences, wherein the transposon segment is integrated by transposition into the cellular nucleic acid of said target cell and the integration is mediated by MuA only;
- and
- b) screening for cells that comprise the selectable marker.
Dependencies are inferred from the claim text.